E. Klein

4.0k total citations
112 papers, 3.2k citations indexed

About

E. Klein is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E. Klein has authored 112 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Immunology, 43 papers in Oncology and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E. Klein's work include Immune Cell Function and Interaction (36 papers), Immunotherapy and Immune Responses (35 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). E. Klein is often cited by papers focused on Immune Cell Function and Interaction (36 papers), Immunotherapy and Immune Responses (35 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). E. Klein collaborates with scholars based in Sweden, United States and Hungary. E. Klein's co-authors include George Klein, Farkas Vánky, Peter Clifford, George Klein, Maria G. Masucci, Hans Wigzell, Shmuel Argov, Jan Stjernswärd, E W Lamon and B. M. Vose and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

E. Klein

110 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E. Klein 1.8k 1.5k 541 514 485 112 3.2k
Joyce D. Fingeroth 1.2k 0.6× 1.8k 1.2× 1000 1.8× 473 0.9× 661 1.4× 45 3.1k
R. L. H. Bolhuis 3.2k 1.8× 2.0k 1.3× 489 0.9× 795 1.5× 330 0.7× 105 4.6k
Pierre Garrone 2.6k 1.4× 581 0.4× 416 0.8× 602 1.2× 270 0.6× 34 3.6k
Danièle Brouty‐Boyé 1.2k 0.6× 839 0.6× 288 0.5× 904 1.8× 161 0.3× 70 3.0k
P A Biro 1.2k 0.7× 537 0.4× 312 0.6× 1.1k 2.1× 217 0.4× 40 3.0k
Satoru Kumaki 3.5k 1.9× 1.1k 0.7× 566 1.0× 606 1.2× 204 0.4× 74 4.3k
Raffaella Meazza 2.5k 1.4× 1.1k 0.7× 254 0.5× 572 1.1× 220 0.5× 70 3.2k
James W. Patterson 1.6k 0.9× 1.4k 0.9× 439 0.8× 974 1.9× 345 0.7× 92 3.2k
Robert E. Humphreys 1.6k 0.8× 506 0.3× 226 0.4× 892 1.7× 297 0.6× 111 2.6k
Joel M. Depper 1.8k 1.0× 386 0.3× 314 0.6× 419 0.8× 171 0.4× 14 2.6k

Countries citing papers authored by E. Klein

Since Specialization
Citations

This map shows the geographic impact of E. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Klein more than expected).

Fields of papers citing papers by E. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Klein. The network helps show where E. Klein may publish in the future.

Co-authorship network of co-authors of E. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of E. Klein. A scholar is included among the top collaborators of E. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Klein. E. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, E.. (2004). Non-proliferative Interactions of Epstein-Barr Virus and Human B Lymphocytes. Folia Biologica. 50(3-4). 131–135. 3 indexed citations
2.
Nagy, Noémi, Miki Takahara, Jun Nishikawa, et al.. (2004). Wild-type p53 activates SAP expression in lymphoid cells. Oncogene. 23(53). 8563–8570. 18 indexed citations
3.
Yefenof, Eitan, et al.. (1995). Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Cancer Immunology Immunotherapy. 41(6). 389–396. 19 indexed citations
4.
Vánky, Farkas, et al.. (1992). Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-γ or by a binding peptide. Cellular Immunology. 142(2). 296–302. 5 indexed citations
5.
Vánky, Farkas, et al.. (1991). Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas. Cancer Immunology Immunotherapy. 33(1). 65–69. 7 indexed citations
6.
Stuber, György, Farkas Vánky, Éva Pócsik, M. Benczúr, & E. Klein. (1990). Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. Cancer Immunology Immunotherapy. 31(2). 76–80. 3 indexed citations
7.
Yefenof, Eitan, et al.. (1989). Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serum. Immunology Letters. 21(4). 303–306. 2 indexed citations
8.
9.
Vánky, Farkas, et al.. (1982). Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.. The Journal of Experimental Medicine. 155(1). 83–95. 64 indexed citations
10.
Blazar, Beverly A., et al.. (1980). Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.. The Journal of Experimental Medicine. 151(3). 614–627. 78 indexed citations
11.
Argov, Shmuel, et al.. (1980). Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.. The Journal of Experimental Medicine. 151(5). 1151–1165. 77 indexed citations
12.
Fenyö, E M, Eitan Yefenof, E. Klein, & George Klein. (1977). Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigens.. The Journal of Experimental Medicine. 146(6). 1521–1533. 25 indexed citations
13.
Klein, E., George Klein, & Paul H. Levine. (1976). Immunological control of human lymphoma: discussion.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(2 pt 2). 724–7. 25 indexed citations
14.
Klein, E., et al.. (1975). Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.. PubMed. 7(2). 297–315. 12 indexed citations
15.
Holtermann, Ole A., et al.. (1975). Regression of cutaneous neoplasms following delayed-type hypersensitivity challenge reactions to microbial antigens or lymphokines.. PubMed. 6(2). 157–68. 11 indexed citations
16.
Lamon, E W, Hans Wigzell, E. Klein, Birger Andersson, & H Skurzak. (1973). THE LYMPHOCYTE RESPONSE TO PRIMARY MOLONEY SARCOMA VIRUS TUMORS IN BALB/c MICE. The Journal of Experimental Medicine. 137(6). 1472–1493. 101 indexed citations
17.
Klein, E. & George Klein. (1972). Tumour-associated antigens. Potential application in research, tumour therapy and tumour prevention.. PubMed. 11(1). 15–22. 2 indexed citations
18.
Lamon, E W, H Skurzak, E. Klein, & Hans Wigzell. (1972). IN VITRO CYTOTOXICITY BY A NONTHYMUS-PROCESSED LYMPHOCYTE POPULATION WITH SPECIFICITY FOR A VIRALLY DETERMINED TUMOR CELL SURFACE ANTIGEN. The Journal of Experimental Medicine. 136(5). 1072–1079. 79 indexed citations
19.
Klein, George, Gary R. Pearson, J. S. Nadkarni, et al.. (1968). RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE OF BURKITT TUMOR CELLS. The Journal of Experimental Medicine. 128(5). 1011–1020. 148 indexed citations
20.
Klein, George, J.J. Nadkarni, Hans Wigzell, et al.. (1967). SURFACE IgM SPECIFICITY ON CELLS DERIVED FROM A BURKITT'S LYMPHOMA. The Lancet. 290(7525). 1068–1070. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joyce D. Fingeroth Breakdown of academic impact, for papers by R. L. H. Bolhuis Breakdown of academic impact, for papers by Pierre Garrone Breakdown of academic impact, for papers by Danièle Brouty‐Boyé Breakdown of academic impact, for papers by P A Biro Breakdown of academic impact, for papers by Satoru Kumaki Breakdown of academic impact, for papers by Raffaella Meazza Breakdown of academic impact, for papers by James W. Patterson Breakdown of academic impact, for papers by Robert E. Humphreys Breakdown of academic impact, for papers by Joel M. Depper
Rankless by CCL
2026